journal
Journals International Journal of Gynec...

International Journal of Gynecological Pathology

https://read.qxmd.com/read/38081059/two-rare-cases-of-paratubal-leydig-cell-nodules-clinical-relevance-and-debated-terminology-of-a-noteworthy-incidentaloma
#21
JOURNAL ARTICLE
Edgar G Fischer
Cells with cytologic and immunohistochemical features of Leydig cells are normally present in the ovary and the ovarian hilum, are testosterone-producing, and have been referred to as ovarian hilus cells. Rarely these cells form nests or nodules in extraovarian sites such as the mesovarium or mesosalpinx. Because they are so rare, these nodules can present a diagnostic challenge when first encountered. This report describes 2 such incidental nodules in the mesosalpinx associated with a small paratubal cyst and suggests that the term Leydig cell nodule be preferred over the nonspecific and confusing historical term ovarian hilus cell nest...
January 1, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38081058/dr-naveena-singh-december-4-1964-october-5-2023-president-elect-international-society-of-gynecological-pathologists
#22
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
January 1, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37668341/uterine-sarcoma-with-eml4-ntrk3-fusion-a-spectrum-of-mesenchymal-neoplasms-harboring-actionable-gene-fusions
#23
JOURNAL ARTICLE
João Víctor Alves de Castro, Pedro José Silva Dos Santos, Henrique Mantoan, Glauco Baiocchi, Graziele Bovolim, Giovana Torrezan, Marcelo Corassa, Antônio Geraldo do Nascimento, Marina De Brot, Felipe D'Almeida Costa, Louise De Brot
NTRK gene fusions are part of a paradigm shift in oncology, arising as one of the main genomic alterations with actionability in the so-called "agnostic setting." In gynecologic pathology, the recent description of uterine sarcoma resembling fibrosarcoma and with NTRK rearrangements ( NTRK -rearranged uterine sarcoma) highlights the importance of recognizing clinicopathological cues that can lead to genomic profiling. Herein, we report the case of a 43-year-old woman presenting with vaginal bleeding and pelvic mass...
January 1, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37406360/a-case-of-uterine-tumor-resembling-ovarian-sex-cord-tumor-with-prominent-myxoid-features
#24
JOURNAL ARTICLE
Koki Ise, Zen-Ichi Tanei, Yoshitaka Oda, Satoshi Tanikawa, Hirokazu Sugino, Yusuke Ishida, Masumi Tsuda, Yuko Gotoda, Kunihiko Nishiwaki, Hiroyuki Yanai, Tadashi Hasegawa, Kazuo Nagashima, Shinya Tanaka
Uterine tumor resembling ovarian sex cord tumor (UTROSCT) is a rare tumor with low malignant potential that commonly occurs in middle age. Although more than 100 cases have been reported to date, myxoid morphology is not well documented. Here, we present a 75-yr-old woman with abnormal vaginal bleeding, with an 8-cm mass in the uterine corpus detected by irregular, high-intensity signaling on T2-weighted imaging. The uterine mass had a glistening mucinous appearance on gross examination. Microscopically, most of the tumor cells were floating in the myxoid stroma...
January 1, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37255420/reconsideration-of-the-diagnostic-criteria-for-an-atypical-placental-site-nodule-comparing-typical-placental-site-nodule-of-the-uterus-a-report-of-two-cases
#25
JOURNAL ARTICLE
Uiree Jo, Gi Hwan Kim, Kyu-Rae Kim
Placental site nodules (PSNs) are non-neoplastic remnants of chorionic-type intermediate trophoblastic cells from a previous gestation that form a well-defined single nodule or multiple nodules in the uterine and extrauterine sites. As the cases of PSNs transformed into gestational trophoblastic tumors were described in the literature, "atypical placental site nodules" (APSNs) have been considered as putative transitional lesions between PSNs and gestational trophoblastic tumors. Although histologic criteria and cutoff point of Ki-67 proliferation index for differentiating an APSN from a typical PSN have not been clearly defined, nodules larger than 5 mm with increased cellularity, a corded or nested appearance, marked nuclear atypia, increased mitotic activity, and an increased Ki-67 proliferation index (>5% or >8%) of intermediate trophoblastic cells seem to be accepted as diagnostic criteria for APSNs...
January 1, 2024: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38113031/smarca4-brg1-deficient-uterine-neoplasm-with-hybrid-adenosarcoma-and-carcinoma-features-expanding-the-molecular-morphologic-spectrum-of-smarca4-driven-gynecologic-malignancies
#26
JOURNAL ARTICLE
Christina H Wei, Evita Sadimin, Mark Agulnik, Susan E Yost, Teri A Longacre, Oluwole Fadare
SMARCA4 gene encodes BRG1, a member of the SWItch/sucrose non-fermentable protein family involved in epigenetic transcriptional regulation of important cellular processes. In the uterine corpus, SMARCA4/BRG1 deficiency is associated with a novel class of undifferentiated uterine sarcomas, characterized by younger age onset, rhabdoid histology, focal phyllodiform architecture, high-risk pathologic findings, and dismal prognosis. Herein, we report a case of a 34-year-old Asian woman with a SMARCA4/BRG1-deficient uterine tumor fulfilling the clinicopathologic features of an undifferentiated uterine sarcoma...
December 12, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38085951/prame-immunohistochemistry-for-distinguishing-vulvar-and-vaginal-melanoma-from-benign-melanocytic-nevi
#27
JOURNAL ARTICLE
Spencer D Martin, Karina C Martin, C Blake Gilks, Richard I Crawford, Lien N Hoang
Vulvovaginal melanoma (VVM) is a rare but deadly disease, accounting for 5% of all vulvar malignancies, with a 5-yr survival rate of only 47% for all stages of the disease. VVM is a distinct subset of melanoma, with a unique genomic profile and underlying pathogenesis unassociated with sun exposure. Distinguishing these rare malignancies from very common pigmented lesions of the vulva and vagina is challenging as histologic features often overlap between entities. PReferentially expressed Antigen in MElanoma (PRAME) is a melanoma-associated protein, and immunohistochemistry (IHC) for PRAME distinguishes cutaneous, oral mucosal, and retinal melanoma from atypical nevi...
December 6, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38085958/preferentially-expressed-antigen-in-melanoma-expression-in-uterine-and-ovarian-carcinosarcomas
#28
JOURNAL ARTICLE
Alaaeddin Alrohaibani, Yun Yu, Lina Gao, Kimberly M McLean, Jonathon Hetts, Ozlen Saglam
Carcinosarcoma (CS) is an aggressive form of gynecologic malignancy that accounts for ~5% of carcinomas in the endometrium and ovaries. There has been no significant improvement in survival over the last decades despite additional treatment options. PReferentially Expressed Antigen in MElanoma (PRAME) is an immunotherapy target used for the treatment of several solid tumors. We explored the PRAME protein expression levels in ovarian and uterine CS (n = 29). The expression levels were recorded by H-score (percentage of positively stained cells multiplied by staining intensity) in carcinomatous and sarcomatous components separately and compared by paired t-test...
November 13, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38085954/ovarian-mesonephric-like-adenocarcinoma-recurring-with-a-rhabdomyosarcoma-component-a-case-report
#29
JOURNAL ARTICLE
Akiko Yamamoto, Takeshi Nagai, Aoi Sukeda, Manami Kajiwara, Masaharu Fukunaga, Toru Sasaki, Yuta Kinoshita, Motoshige Hayashi, Shigehiro Hayashi, Masataka Ono, Masayuki Futagami, Hirotaka Nishi
Mesonephric-like adenocarcinoma (MLA) has recently been described as a tumor of the endometrium or ovaries, which, morphologically and immunohistochemically, resembles mesonephric adenocarcinoma arising mostly in the uterine cervix. Herein, we report, to our knowledge, the first case of ovarian MLA that developed into an extremely rapidly growing recurrent mesonephric-like carcinosarcoma, as confirmed by a genomic profiling test. A 51-year-old woman underwent chemotherapy with complete debulking surgery for ovarian carcinoma...
November 13, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38085960/immunohistochemical-expression-of-lymphoid-enhancer-binding-factor-1-in-low-grade-endometrial-stromal-tumors
#30
JOURNAL ARTICLE
Shuo Niu, Haiyan Lu, Wencheng Li, Yanjun Hou
Endometrial stromal tumors (ESTs) are uncommon uterine mesenchymal lesions. Nuclear expression of β-catenin, an indication of activated Wnt/β-catenin signaling pathway, was described in 50% to 92% of low-grade ESTs, including endometrial stromal nodule and low-grade endometrial stromal sarcoma. Activation of the Wnt/β-catenin signaling pathway leads to the translocation of β-catenin into the nucleus and interaction with the T-cell factor/lymphoid enhancer-binding factor-1 (LEF1) family of transcription factors to regulate cell proliferation, differentiation, migration, and survival...
November 10, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/38085957/proposal-of-novel-binary-grading-systems-for-cervical-squamous-cell-carcinoma
#31
JOURNAL ARTICLE
Simona Stolnicu, Aaron M Praiss, Douglas Allison, Basile Tessier-Cloutier, Jessica Flynn, Alexia Iasonos, Lien Hoang, Cristina Terinte, Anna Pesci, Claudia Mateoiu, Ricardo R Lastra, Takako Kiyokawa, Rouba Ali-Fehmi, Mira Kheil, Esther Oliva, Kyle Devins, Nadeem Abu-Rustum, Robert A Soslow
We compared grading systems and examined associations with tumor stroma and survival in patients with cervical squamous cell carcinoma. Available tumor slides were collected from 10 international institutions. Broders tumor grade, Jesinghaus grade (informed by the pattern of tumor invasion), Silva pattern, and tumor stroma were retrospectively analyzed; associations with overall survival (OS), progression-free survival (PFS), and presence of lymph node metastases were examined. Binary grading systems incorporating tumor stromal changes into Broders and Jesinghaus grading systems were developed...
November 9, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37562066/zc3h7b-bcor-fusion-high-grade-endometrial-stromal-sarcoma-with-morphologic-features-of-low-grade-endometrial-stromal-sarcoma-a-case-report-and-review-of-literature
#32
REVIEW
Longmei Zhao, Yu-Wei Cheng, Maria Luisa C Policarpio-Nicolas
High-grade endometrial stromal sarcomas with ZC3H7B-BCOR fusion are rare. They are predominantly located in the endomyometrium, with morphologic features characterized as haphazardly arranged fascicles of spindle cells with mild to moderate atypia, abundant myxoid matrix, high mitotic index, and tongue-like/pushing patterns of myometrial invasion. Furthermore, conventional or variant low-grade endometrial stromal sarcomas are often not present. Clinically, they present at a higher stage and are associated with worse prognosis compared with low-grade endometrial stromal sarcoma...
November 1, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/36867505/ovarian-immature-teratoma-with-nodal-gliomatosis-a-case-report-and-literature-review
#33
REVIEW
Marwa Alna'irat, W Glenn McCluggage, Maysa Al-Hussaini
Gliomatosis involving lymph nodes (nodal gliomatosis) is rarely encountered in association with an ovarian teratoma, with 12 cases previously reported. We report this rare occurrence in a 23-yr-old female with an ovarian immature teratoma. The ovary contained a grade 3 immature teratoma, with immature neuroepithelium. A subcapsular liver mass contained metastatic immature teratoma with neuroepithelium. The omentum and peritoneum contained mature glial tissue, consistent with gliomatosis peritonei with no evidence of immature elements...
November 1, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/36706438/ovarian-clear-cell-carcinoma-and-markers-of-epithelial-mesenchymal-transition-emt-immunohistochemical-characterization-of-tumor-budding
#34
JOURNAL ARTICLE
Lawrence Hsu Lin, Ronaldo DeLeon Zamuco, Pratibha S Shukla
Tumor budding, largely considered a manifestation of epithelial-mesenchymal transition (EMT) is an established prognostic marker for several cancers. In a recent study, tumor budding was associated with poor clinical outcomes in early-stage ovarian clear cell carcinoma. Here, we evaluated the immune expression of 3 proteins shown to be associated with EMT (E-cadherin, β-catenin, and glypican-3) in 72 primary tumors of ovarian clear cell carcinoma with median follow-up of 39.47 mo. E-cadherin and β-catenin expression was further evaluated in tumor buds in 29 (40%) cases...
November 1, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37922954/metastatic-hepatocellular-carcinoma-represents-an-important-but-rare-pitfall-in-the-diagnostic-evaluation-of-er-negative-ovarian-malignancy-a-case-report
#35
JOURNAL ARTICLE
Mthulisi Viki, Rebecca Morrow
Metastatic hepatocellular carcinoma (HCC) to the ovary is a rare and challenging histopathological diagnosis in the absence of the relevant clinical history. The differential diagnoses of a hepatoid tumor in the ovary are extensive, and correct diagnosis requires well-considered clinical-pathologic correlation. Familiarity with the diverse architectural patterns and immunophenotype of HCC is essential; however, even in the setting of known hepatic disease, a well-developed pseudoglandular pattern may be a convincing morphologic mimic of a primary surface epithelial ovarian malignancy...
October 4, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37922951/prospective-clinical-prognostication-of-endometrial-carcinomas-based-on-next-generation-sequencing-and-immunohistochemistry-real-world-implementation-and-results-at-a-tertiary-care-center
#36
JOURNAL ARTICLE
Kurtis D Davies, Lynelle P Smith, Amy Guimaraes-Young, Bradley R Corr, Christine M Fisher, Saketh R Guntupalli, Amber A Berning, Miriam D Post, Devon Pino, Dara L Aisner, Rebecca J Wolsky
Based on findings from The Cancer Genome Atlas and the Proactive Molecular Risk Classifier for Endometrial Cancer algorithm, endometrial carcinoma can now be stratified into 4 prognostically distinct subgroups based on molecular alterations and immunohistochemical (IHC) aberrations. In this study, we describe the de novo adoption and clinical reporting of prognostic subgroup classification based on next-generation sequencing (NGS) and IHC analyses of all endometrial carcinoma resections at a single institution, framed by the Exploration, Preparation, Implementation, and Sustainment model...
October 4, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37922949/fibroepithelial-stromal-polyp-of-the-vulvovaginal-region-as-part-of-the-rb1-family-of-tumors-friend-or-foe
#37
JOURNAL ARTICLE
Fleur Cordier, Nadine Van Roy, Bart Matthys, Pascale De Paepe, Koen Van de Vijver, Jo Van Dorpe, David Creytens
Fibroepithelial stromal polyps (FSPs) are benign mesenchymal lesions occurring in the vulvovaginal region. Following the identification of loss of Retinoblastoma 1 (RB1) on immunohistochemical staining in routine practice, we stained a series of FSPs and performed additional fluorescence in situ hybridization (FISH) and copy number variation (CNV) sequencing to detect losses/deletions in the Retinoblastoma transcriptional corepressor 1 (RB1) gene. Fifteen FSP cases were stained for RB1, and subsequently, 9 cases were examined by FISH to detect a loss of RB1 (13q)...
October 4, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37922943/synchronous-bilateral-ovarian-mesonephric-like-adenocarcinomas-with-separate-origins-from-high-grade-mullerian-adenosarcoma-and-endometriosis-report-of-a-rare-case
#38
JOURNAL ARTICLE
Zitong Zhao, Ravichandran Nadarajah, Inny Busmanis
Mesonephric-like adenocarcinoma (MLA) of the ovary is a recently recognized, rare malignancy with aggressive clinical behavior, and is thought to originate from Mullerian epithelium with mesonephric transdifferentiation. Emerging evidence suggests that MLA may be classified as an endometriosis-associated neoplasm. The presence of a sarcomatous component within MLA is extremely rare, with common differential diagnoses including the spindle cell component of MLA, carcinosarcoma, as well as mixed Mullerian adenocarcinoma and adenosarcoma...
October 4, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37922887/the-relationship-between-melatonin-1-2-receptor-expression-in-patients-with-epithelial-ovarian-cancer-and-survival
#39
JOURNAL ARTICLE
Elifnur Bicer, Tugan Bese, Deniz Dilan Tuzun, Sennur Ilvan, Basak Ozge Kayan, Fuat Demirkiran
Melatonin has antiproliferative, antiangiogenic, apoptotic, and immunomodulatory properties in ovarian cancer. Considering those, we evaluated the relationship between melatonin 1 (MT1) and melatonin 2 receptor (MT2) expression in tumor tissues of patients with epithelial ovarian cancer, disease-free survival (DFS), and overall survival (OS). Patients who received primary surgical treatment for epithelial ovarian cancer in our clinic between 2000 and 2019 were retrospectively scanned through patient files, electronic databases, and telephone calls...
October 4, 2023: International Journal of Gynecological Pathology
https://read.qxmd.com/read/37922950/endometrioid-adenocarcinoma-with-burrowing-invasion-of-the-cervix-represents-a-separate-primary-from-the-concurrent-uterine-corpus-endometrial-endometrioid-adenocarcinoma-histology-immunohistochemistry-and-next-generation-sequencing-study-of-a-single-case
#40
JOURNAL ARTICLE
Yan Li, Jackson Chen, Shuang Niu
A small subset of endometrial endometrioid adenocarcinoma cases first reported in 2003, showed a distinct cervical component with a so-called "burrowing" invasion pattern. Initially, the cervical component was regarded as cervical involvement by the endometrial adenocarcinoma. However, a 2010 study argued that these cases actually might represent separate primary endometrial and cervical endometrioid adenocarcinomas. However, additional data on this topic are scarce. Here, we report a case of endometrioid adenocarcinoma with a "burrowing" cervical invasion that is morphologically distinct from the patient's endometrial endometrioid adenocarcinoma...
September 22, 2023: International Journal of Gynecological Pathology
journal
journal
28436
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.